Agilent Technologies Inc. (A) Signs Exclusive Supply Agreement to Provide Components for LipoScience, Inc.’s Vantera Clinical Analyzer
9/7/2012 10:10:27 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has entered into an exclusive supply agreement with LipoScience Inc. to provide nuclear magnetic resonance (NMR) components for LipoScience’s Vantera Clinical Analyzer. The analyzer is the first fully-automated NMR diagnostic platform designed specifically for the clinical laboratory and cleared by the U.S. Food and Drug Administration.
comments powered by